VI Urologic Center Inc.
Your Practice Online

JOINT COMMISSION ACCREDITED


VI Urologic Center Inc. : 340-774-9655
 
 
About Us

John R. Franklin, M.D., M.A
Board Certified Urologist

Education

John R. Franklin, M.D., M.A – Board Certified Urologist
John R. Franklin, M.D., M.A

Public Health School:

  • Columbia School of Public Health (Epidemiology)
    M.P.H., [Degree expected when final paper finished]

  • UCLA School of Public Health, Department of Epidemiology, M.P.H., September 1996 - June 1997

Medical School:

  • Columbia University College of Physicians and
    Surgeons, M.D. Degree - May 1988

  • College/Graduate Queens College, Queens, New York

School:

  • Premedical Program, Major in Chemistry
    B.A. Degree, Cum Laude - September 1980 to May 1984

  • Queens College, Queens, New York
    Premedical Program, Major in Chemistry
    M.A. Degree - September 1980 to May 1984

Postgraduate Experience

  • Staff Physician III - Urology
    The Roy L. Schneider Hospital
    February 2000 to Present

  • Staff Physician - Urology
    Juan Luis Hosptital.
    2002 to Present

  • Director
    Virgin Islands Urologic Center, Inc.
    February 2000 to Present

  • Assistant Professor of Urology
    Columbia University
    March 1998 – January 2000

  • Assistant Attending
    New York Presbyterian Hospital
    March 1998 – January 2000

  • Assistant Attending
    St. Lukes/Roosevelt Hospital
    January 1998 to January 2000

  • Assistant Professor in Urology (Oncologist)
    Albert Einstein College of Medicine/Montefiore Medical Center
    July 1997 - January 1998

  • Urologic Oncologist
    West Los Angeles, Veterans Affairs Medical Center (Wadsworth)
    July 8, 1996 - July 1997

  • Co-Chairman, Prostate Cancer Center of Excellence
    West Los Angeles, Veterans Affairs Medical Center (Wadsworth)
    December 1996 - July 1997

  • Assistant Clinical Professor
    UCLA School of Medicine, Department of Urology
    July 1, 1996 - June 1997

  • Research Urologic Oncology Fellow/Clinical Instructor
    UCLA School of Medicine, Division of Urology, Department of Surgery
    July 1995 - June 1996

  • Clinical Urologic Oncology Fellow/Clinical Instructor
    UCLA School of Medicine, Division of Urology, Department of Surgery
    July 1994 - June 1995

  • Urology Residency
    Columbia University, Urology Department
    July 1990 - June 1994

  • Research
    Columbia University, Urology Research Department
    July 1989 - June 1990

  • Internship
    Nassau County Medical Center
    Categorical General Surgical Residency
    July 1, 1988 - June 30, 1989

Board Certification

1998 American Board of Urology (Diplomate)

License

  • Virgin Islands Medical License
    January 3, 2000 (active)

  • New York State Medical License
    August 17, 1989 (active)

  • DEA Number BF3929190
    Expiration
    September 2007

Professional Organizations

  • American Urologic Association (National)
  • AUA (New York Section)
  • National Medical Association

Journal Review

  • Peer Reviewer, The Journal of Urology
  • Peer Reviewer, Urology

Awards

  • UCLA’s Department of Epidemiology, School of Public Health Traineeship Award - 1996
  • National Institute of Health, Tumor Immunology Training Grant - June 1995
  • American Foundation for Urologic Disease, Inc., National Kidney Foundation Joint Resident Fellowships - 1992
  • First Prize Essay Contest Winner - The Society of Basic Urologic Research - 1992
  • Salk Scholar Award - 1984
  • Queens College Graduate Student Award - 1984
  • Queens College Division of Mathematics and the Natural Sciences Award - Honors in Chemistry - 1984

Approved Grants and Research Support

  • Principal Investigator: A National Phase II Trial of Intron, Interferon alfa Treatment of Superficial Bladder Cancer. Schering. Dates 11/1999 to 1/31/2000

  • Principal Investigator: Race/Ethnic based genetic variations in human genes: Defining the genetic evidence for disparity of prostate cancer risk and mortality between different populations. Department of Defense, Prostate Cancer Research Program, Minority Population Focused Training Award. Dates 2/15/99 to 8/14/99

  • Principal Investigator: A phase II open randomized multi-center trial to determine the efficacy and safety of the combination of liarozole with prednisone in patients with relapse hormone-resistant prostate cancer. LIA-INT-29. Janssen Research Foundation

  • Principal Investigator: International phase II randomized double blind, multi-center study of liarozole in patients with rising PSA after definitive therapy. LIA-INT-26. Janssen Research Foundation

  • Co-Investigator: Ethnicity and Veteran Identity as Determinants of VA Ambulatory Care Use (Pending minor revisions)

References

  1. Belldegrun AS, Franklin JR, O’Donnell MA, Gomella LG, Klein E, Neir R, Nseyo UO, Ratliff TL, and Richards W: Superficial Bladder Cancer: The role of Interferon alpha therapy. J Urol, 159:1793-1799, (1998)

  2. Figlin R, Gitlitz B, Franklin J, Dorey F, Moldawer N, Rausch J, deKernion J, and Belldegrun A: Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients. Cancer J Scientific Amer., 3(suppl 1): 92-97, (1997)

  3. Hoh C, Spencer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A: Positron emission tomography in urologic oncology. J Urol, 159: 347-356, (1997)

  4. Patel A, Dorey F, Franklin J, and deKernion J: Recurrence patterns after radical retropubic prostatectomy: Clinical utility of PSA doubling times and log slope PSA (prostate specific antigen). J Urol., 158: 1441-1445, (1997)

  5. Franklin JR, and Belldegrun AS: Tumor immunity. In Oesterling J, and Richie J (eds), Urologic Oncology. Philadelphia PA, Saunders, pp 34-52, (1997)

  6. Franklin JR, Figlin R, Rauch J, Gitlitz B, Dorey F, deKernion JB, and Belldegrun AS: The role of cytoreductive surgery in the management of metastatic renal cell carcinoma. Seminars in Urologic Oncology 14 (4):230 (1996)

  7. Franklin JR, Figlin R, Belldegrun AS: Renal cell carcinoma: Basic biology and clinical behavior. Seminars in Urologic Oncology 14 (4):208 (1996)

  8. Franklin JR, Raz S, deKernion JB: Female neobladder construction utilizing the UCLA 1 (ileocolic) pouch. In Olsson CA (ed), Surgical Techniques in Urology. 8 (5) (1995)

  9. Franklin JR, deKernion JB: Kidney tumors - what’s new? Current Opinions in Urology 5 (5):225 (1995)

  10. Belldegrun A, Franklin JR, Figlin R: Prognostic factors in renal cell carcinoma. J Urol. 154:1274 (1995)

  11. deKernion JB, Franklin JR, Belldegrun A, and Smith RB. Surgery for Clinically Localized Prostate Cancer. In RTD Oliver et al. (ed), Preventing Prostate Cancer: Screening versus Chemoprevention. Cold Spring Harbor Laboratory Press New York, pp 315-320 (1995)

  12. Franklin JR, and deKernion JB. Surgical Approaches To Renal Cell Carcinoma. in MS Ernstoff et al. (ed), Urologic Cancer. W.W. Norton & Company, N.Y., London (1996)

  13. Franklin J, and Benson M. New Techniques in Management and Treatment of Superficial Bladder Cancer. In DE Neal (ed.), Tumours in Urology. Springer-Verlag London Berlin Heidelberg New York, pp 65-78 (1994)

  14. Franklin JR, Olsson CA, and Sawczuk IS. Safety of Urologic Surgical Interventions in the Elderly. Geriatric Nephrol. and Urol. 2: 105 (1992)

Presentations at Professional Meetings Published as Abstracts

  1. Franklin JR: Endoscopic treatment for papillary TCC of upper tract. National Medical Association. August 2-7, 1997

  2. Franklin JR, Pang S, Dannul J. Sawyer C, Kaboo R, Tso C-L, and Belldegrun A: An Upstream regulatory region augments prostate specific antigen (PSA) promoter activity: In vivo studies. National Medical Association. August 2-7, 1997

  3. Franklin JR, Dorey J, Patel A, Litwin MS, deKernion J: Improved continence after radical retropubic prostatectomy: A modified apical dissection. National Medical Association. August 2-7, 1997

  4. Franklin J, Pang S, Dannul J, Sawyer C, Kaboo R, Tso C-L, and Belldegrun A: Cloning of an upstream regulatory region augments prostate specific antigen (PSA) promoter activity: In vivo studies. (Abstract) accepted AUA, April, 1997

  5. Belldegrun A, Franklin J, Dorey F, Rauch J, deKernion J, and Figlin R: Immunotherapy for renal cell carcinoma: The UCLA experience. (Abstract) accepted AUA, April, 1997

  6. Seltzer M, Hoh C, Franklin J, Naitoh J, Gitlitz B, Figlin R, Silverman D, deKernion J, Phelps M, Belldegrun A: Positron emission tomography (PET) imaging for staging of renal, testicular, and prostatic neoplasms. (Abstract) accepted AUA, April, 1997

  7. Naitoh J, Franklin J, Patel A, and deKernion J: Comparing results of patient-based and physician-based reported rates of urinary incontinence following radical prostatectomy. (Abstract) accepted AUA, April, 1997

  8. Hoh CK, Figlin RA, Seltzer MA, Belldegrun A, Franklin J, Gitlitz B, Phelps ME, Maddahi J: Prognostic value of a whole body FDG PET vs conventional imaging for the evaluation of biologic therapy in renal cell carcinoma. (Abstract) The Society of Nuclear Medicine 44th Annual Meeting, June, 1997

  9. deKernion JB, Franklin J, and Patel A: Radical retropubic prostatectomy: Improved continence after a modified apical dissection. Western Section American Urological Association (72nd Annual Meeting). (Abs. 3) Jul 28 - Aug 1, 1996

  10. Belldegrun A, Franklin J, Dorey F, Gitlitz B, Rauch J, deKernion J, Figlin R: Patients with metastatic cell carcinoma (mRCC) treated with IL-2 based immunotherapy with or without tumor infiltrating lymphocytes: Long term survival. Western Section American Urological Association (72nd Annual Meeting). (Abs. 109) Jul 28 - Aug 1, 1996

  11. Franklin J, Dorey F, Gitlitz B, deKernion J, Figlin R, and Belldegrun A: The role of combination surgery and immunotherapy in the management of advanced renal cell carcinoma. Western Section American Urological Association (72nd Annual Meeting). (Abs. 110) Jul 28 - Aug 1, 1996

  12. Franklin JR, deKernion JB, Patel A, Smith RB, Dorey F, and Rajfer J: Peyronie’s disease occurring after radical retropubic prostatectomy: Fact or friction. Western Section American Urological Association (72nd Annual Meeting). (Abs. 166) Jul 28 - Aug 1, 1996

  13. Hoh CK, Figlin RA, Belldegrun A, Moon DH, Franklin J, Phelps ME, and Maddahi J: Evaluation of renal cell carcinoma with whole body FDG PET. Proceeding of the 43rd annual meeting of the society of nuclear medicine. J Nuclear Med., 37(suppl): 141P, 1996

  14. Franklin J, Marks L, Dorey F, Shery ED, and deKernion J: Serum PSA levels following TURP in men with BPH: Long-term characterization. Proceeding of the American Urologic Association. J Urol., 155(suppl): 378A, 1996

  15. Belldegrun A, Franklin J, Dorey F, Rauch J, deKernion J, and Figlin R: Long term survival of 181 patients with metastatic renal cell carcinoma (mRCC) treated with IL-2 based immunotherapy with/without tumor infiltrating lymphocytes. Proceeding of the American Urologic Association. J Urol., 155(suppl): 385A, 1996

  16. Sokoloff M, Tso C-L, Franklin J, Nelson S, Dorey F, deKernion J, and Belldegrun A: Quantitative polymerase chain reaction [PCR] does not improve prostate cancer [PC] staging: A clinical-pathologic-molecular analysis of 121 patients. Proceeding of the American Urologic Association. J Urol., 155(suppl): 417A, 1996

  17. Franklin J, Pang S, Sawyer C, Kaboo R, Tso C-L, deKernion J, and Belldegrun A: Prostate specific gene therapy using a novel PSA promoter: In vivo studies. Proceeding of the American Urologic Association. J Urol., 155(suppl): 437A, 1996

  18. Dorey F, Franklin J, deKernion J, and Smith R: Use of multiple PSA values for predicting clinical disease recurrence after radical retropubic prostatectomy (RRP). Proceeding of the American Urologic Association. J Urol., 155(suppl): 487A, 1996

  19. Franklin J, Dorey F, Gitlitz B, deKernion J, Figlin R, and Belldegrun A: Cytoreductive nephrectomy in 63 consecutive patients who received adoptive immunotherapy for advanced renal cell carcinoma. Proceeding of the American Urologic Association. J Urol., 155(suppl): 500A, 1996

  20. Franklin J, Hoh C, Gitlitz B, Phelps M, Figlin R, and Belldegrun A: Positron emission tomography (PET) scan for imaging of advanced renal cell carcinoma (RCC). Proceeding of the American Urologic Association. J Urol., 155(suppl): 581A, 1996

  21. Sokoloff M, Tso C-L, Randhir K, Franklin J, deKernion J, Pang S, Belldegrun A: Super-sensitive and quantitative polymerase chain reaction (PCR): An innovative technique for staging and monitoring prostate cancer. J Urol 153:294A, 1995

  22. deKernion J, and Franklin J: Improved preservation of continence after radical prostatectomy or cystectomy. Pan African Urological Surgeons’ Association (2nd Biennial Conference) Sept 4-8, 1995

  23. deKernion J, Raz S, Franklin J, and Seto E: Long-term results of the continent ileocecal urinary reservoir. Pan African Urological Surgeons’ Association (2nd Biennial Conference) Sept 4-8, 1995

  24. Franklin JR, Raz S, and deKernion JB: Ileocolonic female neobladder. Western Section American Urological Association (71st Annual Meeting). (Abs. 168) Nov 5-9, 1995

  25. deKernion JB, Trapasso JG, Franklin JR: Improved continence following radical retropubic prostatectomy: a modified apical dissection. Western Section American Urological Association (71st Annual Meeting). (Abs. 78) Nov 5-9, 1995

  26. Franklin JR, and deKernion JB: Radiation therapy for localized recurrence after radical retropubic prostatectomy. Western Section American Urological Association (71st Annual Meeting). (Abs. 233) Nov 5-9, 1995

  27. Sokoloff M, Tso C-L, Kaboo R, Franklin J, deKernion J, Pang S, Figlin R, and Belldegrun A: Improved prostate cancer (PC) staging using super-sensitive and quantitative polymerase chain reaction (PCR). Western Section American Urological Association (71st Annual Meeting). (Abs. 51) Nov 5-9, 1995

  28. Barbara GJ, Franklin JR, Figlin, RA, William P, deKernion J, Belldegrun A: Tumor infiltrating lymphocyte (TIL) based therapy for metastatic renal cell carcinoma (RCC). The UCLA Kidney Cancer Program. National Medical Association (Centennial Meeting). July 30, 1995

  29. Franklin, JR, and Hensle, T: Conservative management of renal pelvic lesions in children. Pan African Urological Surgeons Association (Inaugural international conference). Harare, Zimbabwe, May 1992

  30. Franklin JR, Olsson CA, and Buttyan R. Homeobox gene expression in the mammalian prostate gland. Pan African Urological Surgeons Association (Inaugural international conference). Harare, Zimbabwe, May 1992

  31. Franklin JR, Olsson CA, and Buttyan R. Expression of homeobox genes in the rat ventral prostate gland. J Urol 147: 318A (1992)

  32. Franklin, J: The novel expression of homeobox genes in the mammalian prostate. Ferdinand C. Valentine Urology Residents’ Essay Meeting. (The New York Section of the AUA, Inc., April 1992) Abstract 74

  33. Franklin JR, and Bittman R, Ph.D. Synthesis of the alkyl ether phospholipid, rac-glycerol-3-phosphorylcholine 1-dodecyl ether 2-eicosyl ether and 1-eicosyl ether 2-dodecyl ether. 17th marm Abstract Booklet (ACS, April 1983) p. 208

Manuscripts in Preparation

  • Franklin JR, Dorey J, Patel A, Litwin MS, deKernion J: Improved continence after radical retropbic prostatectomy: A modified apical dissection

Additional Experience

Franklin Freighting - July 1979 - March 1980

  • Worked with father on Freighter

Road Primary School in Anguilla - April 1980 - July 1980

  • Taught students in Primary School

Faith Tabernacle Baptist Church - June 1984 - August 1984

  • Coordinated and taught in the summer educational program for junior and high school students in the Jamaica, New York area

Columbia University - June 1985 - August 1985

  1. Taught MCAT preparation course summer of 1985
  2. Taught College Preparation Course to pre-college students

Extra Curricular Activities

  • Scuba Diving (Certified Advanced Diver), Swimming, Traveling, and Reading
Services
 
John R. Franklin, M.D., M.A - Board Certified Urologist John R. Franklin, M.D., M.A - Board Certified Urologist
Read more
Newsletter
Patient Forms
Facebook Twitter Youtube Linkedin
Bookmark and Share
© VI Urologic Center Inc. Urinary Incontinence Urological Cancer Virgin Islands